Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
772
-
Total 13F shares, excl. options
-
370M
-
Shares change
-
+276M
-
Total reported value, excl. options
-
$27.6B
-
Value change
-
+$20.1B
-
Put/Call ratio
-
1.13
-
Number of buys
-
747
-
Number of sells
-
-151
-
Price
-
$74.53
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q2 2022
966 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q2 2022.
DEXCOM INC - Common Stock (DXCM) has 772 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 370M shares
of 392M outstanding shares and own 94.42% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (43.2M shares), BlackRock Inc. (33.4M shares), BAILLIE GIFFORD & CO (18.1M shares), SANDS CAPITAL MANAGEMENT, LLC (17.9M shares), STATE STREET CORP (16.2M shares), JPMORGAN CHASE & CO (10.4M shares), FMR LLC (10.4M shares), JENNISON ASSOCIATES LLC (8.56M shares), Nuveen Asset Management, LLC (8.29M shares), and GEODE CAPITAL MANAGEMENT, LLC (7.82M shares).
This table shows the top 772 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.